[2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide

C36H64BrNO4 — CID 158460455

IUPAC[2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide
SMILESC.CC1(C)CC[C@]23CC[C@]4(C)C(CCC5[C@@]6(C)CC[C@H](OC(=O)C[N+](C)(C)CCO)C(C)(C)C6CC[C@]54C)C2[C@H]1O3.[Br-]
InChIInChI=1S/C35H60NO4.CH4.BrH/c1-30(2)16-18-35-19-17-33(6)23(28(35)29(30)40-35)10-11-25-32(5)14-13-26(39-27(38)22-36(8,9)20-21-37)31(3,4)24(32)12-15-34(25,33)7;;/h23-26,28-29,37H,10-22H2,1-9H3;1H4;1H/q+1;;/p-1/t23?,24?,25?,26-,28?,29+,32-,33+,34+,35-;;/m0../s1
InChIKeyNDYCLPLGUJLZRU-OASIOVDVSA-M
MW654.82 g/mol
LogP4.25
Rot. Bonds5

About [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide

[2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide (PubChem CID 158460455) has the molecular formula C36H64BrNO4 and a molecular weight of 654.82 g/mol. Its IUPAC name is [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide.

Molecular Properties

Compound Name[2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide
PubChem CID158460455
Molecular FormulaC36H64BrNO4
Molecular Weight654.82 g/mol
Exact Mass653.40
IUPAC Name[2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide
SMILESC.CC1(C)CC[C@]23CC[C@]4(C)C(CCC5[C@@]6(C)CC[C@H](OC(=O)C[N+](C)(C)CCO)C(C)(C)C6CC[C@]54C)C2[C@H]1O3.[Br-]
InChIInChI=1S/C35H60NO4.CH4.BrH/c1-30(2)16-18-35-19-17-33(6)23(28(35)29(30)40-35)10-11-25-32(5)14-13-26(39-27(38)22-36(8,9)20-21-37)31(3,4)24(32)12-15-34(25,33)7;;/h23-26,28-29,37H,10-22H2,1-9H3;1H4;1H/q+1;;/p-1/t23?,24?,25?,26-,28?,29+,32-,33+,34+,35-;;/m0../s1
InChIKeyNDYCLPLGUJLZRU-OASIOVDVSA-M
XLogP4.25
TPSA55.76 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500654.82
LogP ≤ 54.25
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide?
The IUPAC name of [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide (CID 158460455) is [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide.
What is the SMILES notation for [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide?
The canonical SMILES for [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide is C.CC1(C)CC[C@]23CC[C@]4(C)C(CCC5[C@@]6(C)CC[C@H](OC(=O)C[N+](C)(C)CCO)C(C)(C)C6CC[C@]54C)C2[C@H]1O3.[Br-].
What is the InChIKey of [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide?
The InChIKey is NDYCLPLGUJLZRU-OASIOVDVSA-M. The full InChI is InChI=1S/C35H60NO4.CH4.BrH/c1-30(2)16-18-35-19-17-33(6)23(28(35)29(30)40-35)10-11-25-32(5)14-13-26(39-27(38)22-36(8,9)20-21-37)31(3,4)24(32)12-15-34(25,33)7;;/h23-26,28-29,37H,10-22H2,1-9H3;1H4;1H/q+1;;/p-1/t23?,24?,25?,26-,28?,29+,32-,33+,34+,35-;;/m0../s1.
What are the key properties of [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide?
[2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide has a molecular weight of 654.82 g/mol, XLogP of 4.25, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[[(1R,4R,5R,10S,13R,19R)-4,5,9,9,13,20,20-heptamethyl-23-oxahexacyclo[17.3.1.01,18.04,17.05,14.08,13]tricosan-10-yl]oxy]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;methane;bromide is sourced from PubChem (CID 158460455), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).